Approved Formulary
Add Formweb to your mobile device
Approved Formulary
Search results for:
LEVOTHYROXINE (IV IS RESTRICTED)
LEVOTHYROXINE (IV IS RESTRICTED)
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| LEVOTHYROXINE SODIUM | POWDER FOR INJECTION | 0.2 mg | ||
| LEVOTHYROXINE SODIUM | POWDER FOR INJECTION | 0.5 mg | ||
| SYNTHROID | TABLET | 0.025 mg | ||
| SYNTHROID | TABLET | 0.05 mg | ||
| SYNTHROID | TABLET | 0.075 mg | ||
| SYNTHROID | TABLET | 0.088 mg | ||
| SYNTHROID | TABLET | 0.1 mg | ||
| SYNTHROID | TABLET | 0.112 mg | ||
| SYNTHROID | TABLET | 0.125 mg | ||
| SYNTHROID | TABLET | 0.15 mg | ||
| SYNTHROID | TABLET | 0.175 mg | ||
| SYNTHROID | TABLET | 0.2 mg | ||
| SYNTHROID | TABLET | 0.3 mg |
View Other Therapeutic Options: Thyroid Agents:
683604
Last updated: Oct. 24, 2018
- Black Box Warning: Not to be used for treatment of obesity
IV dose is 50% oral dose.
Synthroid is an automatic substitution for all oral forms of levothyroxine
Restricted to patients with myxedema coma, or hypothyroid patients who are NPO and unable to tolerate oral formulation after not receiving oral dose for 4 days.
May also be used if recommended by endocrinology or in patients awaiting organ harvest under the direction of the donor network.